Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by KIM-ANH DO and SAMIR HANASH.
KIM-ANH DO
Connection Strength
2.693
SAMIR HANASH
  1. Biomarker trajectory for earlier detection of lung cancer. EBioMedicine. 2024 Oct; 108:105377.
    View in: PubMed
    Score: 0.248
  2. Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study. Cancers (Basel). 2024 May 30; 16(11).
    View in: PubMed
    Score: 0.242
  3. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4969-e4980.
    View in: PubMed
    Score: 0.203
  4. A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer. Cancers (Basel). 2021 Feb 22; 13(4).
    View in: PubMed
    Score: 0.193
  5. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology. 2021 03; 160(4):1373-1383.e6.
    View in: PubMed
    Score: 0.190
  6. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO Precis Oncol. 2020 Nov; 4:426-436.
    View in: PubMed
    Score: 0.189
  7. Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer. J Natl Cancer Inst. 2020 06 01; 112(6):607-616.
    View in: PubMed
    Score: 0.184
  8. Investigating protein patterns in human leukemia cell line experiments: A Bayesian approach for extremely small sample sizes. Stat Methods Med Res. 2020 04; 29(4):1181-1196.
    View in: PubMed
    Score: 0.171
  9. Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer. Cancer Res. 2019 04 01; 79(7):1549-1557.
    View in: PubMed
    Score: 0.167
  10. A metabolite-based liquid biopsy for detection of ovarian cancer. Biomark Res. 2024 Aug 28; 12(1):91.
    View in: PubMed
    Score: 0.062
  11. A novel method to guide biomarker combinations to optimize the sensitivity. bioRxiv. 2024 Apr 15.
    View in: PubMed
    Score: 0.060
  12. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Clin Chem. 2024 01 04; 70(1):102-115.
    View in: PubMed
    Score: 0.059
  13. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine. 2023 Dec; 98:104873.
    View in: PubMed
    Score: 0.058
  14. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2023 Nov 17; 108(12):3260-3271.
    View in: PubMed
    Score: 0.058
  15. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Rep Med. 2023 09 19; 4(9):101194.
    View in: PubMed
    Score: 0.058
  16. Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. J Clin Oncol. 2023 09 20; 41(27):4360-4368.
    View in: PubMed
    Score: 0.057
  17. A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clin Cancer Res. 2022 11 01; 28(21):4669-4676.
    View in: PubMed
    Score: 0.054
  18. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int J Mol Sci. 2022 Aug 11; 23(16).
    View in: PubMed
    Score: 0.053
  19. Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Front Artif Intell. 2022; 5:876100.
    View in: PubMed
    Score: 0.053
  20. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J Natl Cancer Inst. 2022 02 07; 114(2):290-301.
    View in: PubMed
    Score: 0.052
  21. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 2022 03 10; 40(8):876-883.
    View in: PubMed
    Score: 0.051
  22. CES2 sustains HNF4a expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Mol Metab. 2022 02; 56:101426.
    View in: PubMed
    Score: 0.051
  23. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer. Cancers (Basel). 2021 Jul 20; 13(14).
    View in: PubMed
    Score: 0.050
  24. A Deep Learning Approach to Re-create Raw Full-Field Digital Mammograms for Breast Density and Texture Analysis. Radiol Artif Intell. 2021 Jul; 3(4):e200097.
    View in: PubMed
    Score: 0.049
  25. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019 08 08; 178(4):795-806.e12.
    View in: PubMed
    Score: 0.043
  26. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. J Natl Cancer Inst. 2017 03 01; 109(3):1-9.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.